These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 231362)

  • 21. Adenosine-mediated relaxation and activation of cyclic AMP-dependent protein kinase in coronary arterial smooth muscle.
    Silver PJ; Walus K; DiSalvo J
    J Pharmacol Exp Ther; 1984 Feb; 228(2):342-7. PubMed ID: 6694113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of the effects of sodium nitroprusside and of isoproterenol by selective phosphodiesterase inhibitors.
    Lorenz KL; Wells JN
    Mol Pharmacol; 1983 Mar; 23(2):424-30. PubMed ID: 6300651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro.
    Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U
    Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A low dose of forskolin increases cyclic AMP levels and cyclic AMP dependent protein kinase activity in bovine coronary arteries without causing relaxation.
    Vegesna RV; Diamond J
    Proc West Pharmacol Soc; 1984; 27():189-92. PubMed ID: 6093128
    [No Abstract]   [Full Text] [Related]  

  • 25. One-hour exposure to University of Wisconsin solution does not impair endothelium-dependent relaxation or damage vascular smooth muscle of epicardial coronary arteries.
    Ekin ST; Pearson PJ; Evora PR; Schaff HV
    J Heart Lung Transplant; 1993; 12(4):624-33. PubMed ID: 8369325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of cyclic AMP signaling system in rat aortic myocytes in primary culture and aorta.
    Schoeffter P; Lugnier C; Travo C; Stoclet JC
    Lab Invest; 1989 Aug; 61(2):177-82. PubMed ID: 2474090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of noradrenaline and potassium ions on the electrical and contractile activity of coronary artery smooth muscle cells].
    Nikitina EI
    Fiziol Zh SSSR Im I M Sechenova; 1980 Oct; 66(10):1493-8. PubMed ID: 7439440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of adenosine, AMP and papaverine on the cAMP content in thymocytes prelabelled with 14C-adenine].
    Dmitrenko NP; Bukhanevich AM; Goroshnikova TV
    Biull Eksp Biol Med; 1984 Aug; 98(8):181-3. PubMed ID: 6087955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the possible role of cyclic AMP in drug-induced coronary vasodilatation.
    Pöch G; Kukovetz WR
    Adv Cyclic Nucleotide Res; 1972; 1():195-211. PubMed ID: 4353168
    [No Abstract]   [Full Text] [Related]  

  • 30. Adenosine relaxation of isolated vascular smooth muscle.
    Herlihy JT; Bockman EL; Berne RM; Rubio R
    Am J Physiol; 1976 May; 230(5):1239-43. PubMed ID: 179331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.
    Schrör K; Rösen P
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan; 306(1):101-3. PubMed ID: 218118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of adenosine 3',5'-monophosphate content in human astrocytoma cells by isoproterenol and carbachol.
    Gross RA; Clark RB
    Mol Pharmacol; 1977 Mar; 13(2):242-50. PubMed ID: 192991
    [No Abstract]   [Full Text] [Related]  

  • 33. Intracellular cyclic AMP level and intestinal smooth muscle relaxation.
    Inatomi N; Takayanagi I; Uchida M; Takagi K
    Eur J Pharmacol; 1974 Apr; 26(1):73-6. PubMed ID: 4364864
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclic AMP in the rat jugular vein: relationship to vascular relaxation.
    Cohen ML; Landry AS
    Eur J Pharmacol; 1979 Jul; 56(4):305-11. PubMed ID: 225179
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental spasmolytic action of papaverinol and papaveraldine, secondary alkaloids prepared during papaverine synthesis].
    MERCIER F; MERCIER J; SESTIER MR
    C R Seances Soc Biol Fil; 1951 Mar; 145(5-6):408-10. PubMed ID: 14849079
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of a new spasmolytic (Avacan) on the coronary vessels].
    BLOMER H; SCHIMERT G
    Dtsch Med Wochenschr; 1951 Apr; 76(14):477-81. PubMed ID: 14831431
    [No Abstract]   [Full Text] [Related]  

  • 37. [Peridural injection of pantocaine in the treatment of extremital spasms].
    JUNGE H
    Z Orthop Ihre Grenzgeb; 1950; 80(1):84-9. PubMed ID: 14837103
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ataktyl, an obstetrical spasmolytic].
    GUSECK E
    Munch Med Wochenschr; 1950 Dec; 92(35-36):1468-9. PubMed ID: 14806345
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical results with a new spasmolytic (Avacan)].
    HELMUT KRUGER H; KRENTZ C
    Arztl Wochensch; 1951 Mar; 6(10):232-6. PubMed ID: 14818885
    [No Abstract]   [Full Text] [Related]  

  • 40. [Action mechanism of vascular spasmolytics. 5. Drug-related relaxation and adenosine-3',5'-monophosphate content of isolated coronary arteries under conditions of fluoride-induced contracture].
    Fermum R; Möritz KU
    Acta Biol Med Ger; 1979; 38(8):1211-23. PubMed ID: 231362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.